Brief: Vericel Announces FDA Acceptance Of Biologics License Application For NexoBrid

Vericel

16/09/2020 14:22

Sept 16 (Reuters) - Vericel Corp  VCEL.O :
    * VERICEL ANNOUNCES FDA ACCEPTANCE OF BIOLOGICS LICENSE
APPLICATION FOR NEXOBRID FOR THE TREATMENT OF SEVERE THERMAL
BURNS
    * VERICEL CORP -  FDA ASSIGNED A PRESCRIPTION DRUG USER FEE
ACT
(PDUFA) TARGET DATE OF JUNE 29, 2021
    * VERICEL CORP - FDA COMMUNICATED THAT IT IS NOT CURRENTLY
PLANNING TO HOLD AN ADVISORY COMMITTEE MEETING TO DISCUSS
APPLICATION FOR NEXOBRID

Source text for Eikon:  ID:nGNX24Xs5h 
Further company coverage:  VCEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))